Prophetic

Prophetic sits at the intersection of consumer wearables, neuroscience, medical devices, and sleep technology. Its focus is narrower than general-purpose EEG headsets or sleep trackers: the company aims to influence lucid dreaming through ultrasonic neuromodulation rather than only monitor sleep or report sleep metrics. Its described Phase device pairs infrared sensing with spatially steerable ultrasound and adaptive, closed-loop control, while Dual offers a simpler fixed-focus ultrasonic approach. This distinction gives the product portfolio a sensing-and-adjustment option alongside a more straightforward stimulation design. The available company information does not identify direct competitors by name, so a reliable named-company comparison is not possible. Its competitive position will depend on demonstrating that stimulation can safely and consistently affect dream awareness, and that users find the experience useful enough to adopt a dedicated headband. Prophetic is an early-stage private company with $3.4 million raised across pre-seed and seed rounds and a reported employee band of 1–10. That scale indicates a focused development effort rather than an established consumer-device operation. Evidence of repeatable outcomes, product availability, and adoption will be important measures of progress.

Prophetic’s trajectory so far is defined by early financing and product development rather than demonstrated commercial scale. Founded in 2023, the company raised a $1.4 million pre-seed round on October 4, 2023, followed by a $2 million seed round on August 1, 2024. BoxGroup participated as a lead in both rounds, and Escape Velocity was also identified as a pre-seed lead. The $2 million seed financing is the clearest recorded inflection point, bringing total funding to $3.4 million. Media coverage in January 2024 drew attention to the Morpheus One concept; company product information now describes Phase and Dual headband designs with different ultrasound and sensing configurations. Further progress will hinge on translating its technical approach into validated, usable hardware and establishing whether lucid-dreaming stimulation can support durable consumer demand.